Funding News
Jagruti Rehabilitation Centre Raises ₹28 Cr Series A to Scale Organised Mental Health Network
By Mustafa Shariff, Editor in Chief · 03 November,2026 · 2 mins read
Summary
- Jagruti Rehabilitation Centre Raises ₹28 Cr Series A | BHC Media Nov 2026
- Pune-based mental health and addiction care provider Jagruti closes ₹28 Cr Series A led by Alkemi Growth Capital to expand across Tier 1 and Tier 2 Indian cities.
"India's mental health sector needs organised providers with consistent clinical standards." — Alkemi Growth Capital"
Jagruti Rehabilitation Centre, a Pune-based provider of mental health, addiction, and dementia care, raised ₹28 crore in a Series A funding round led by Alkemi Growth Capital, a Delhi-based healthcare-focused venture fund. Announced on 29 October 2026, this is Jagruti's first institutional round — all prior growth was funded through internal accruals, making this a significant inflection point for the company.
About Jagruti Rehabilitation Centre
Jagruti operates as one of India's largest organised platforms for mental health, addiction, and dementia care. The company runs residential and outpatient facilities that provide structured, clinically supervised programmes to individuals struggling with psychiatric disorders, substance dependence, and neurodegenerative conditions. Its model stands out in a sector dominated by small, standalone clinics and independent practitioners who often lack standardised clinical protocols.
Why This Round Matters
Mental healthcare in India remains deeply fragmented, with most care delivered through informal or non-standardised channels. Institutional capacity for residential mental health treatment — especially for addiction and dementia — is severely lacking outside major metros. Jagruti's Series A is also notable as Alkemi Growth Capital's first investment in the mental health and rehabilitation space, signalling growing investor conviction in organised, facility-based behavioural care.
Use of Funds
Jagruti will use the capital to enter new geographies across Tier 1 and Tier 2 cities, expand clinical and staff capacity, develop specialised care programmes, and deepen insurance and corporate partnerships. The company has set an ambitious target of 40+ centres and 4,000+ beds within 3 to 4 years — a substantial scale-up from its current footprint, which the company has grown entirely without external capital.
Alkemi Growth Capital's Portfolio Context
Alkemi Growth Capital has backed several established healthcare names including Redcliffe Labs (diagnostics), Medvital (medical devices), Datar Cancer Genetics, Medulance (emergency medical response), and Alphadroid (autonomous hospital robots). Adding Jagruti extends their thesis into behavioural health — a category with large unmet need and growing public and corporate awareness in post-pandemic India.
Market Backdrop
India has an estimated treatment gap of more than 80% in mental health, meaning the vast majority of people who need care do not receive it. Demand for structured rehabilitation services for addiction and cognitive decline is rising rapidly as urbanisation, workplace stress, and an ageing population converge. Regulatory and policy frameworks around mental health are also improving, opening space for organised providers to scale with insurance and employer support.
What's Next
With institutional backing secured, Jagruti is expected to accelerate clinical hiring, initiate construction or acquisition of new facility sites in target cities, and build out employer and insurer partnerships. The company's national expansion will be closely watched as a test of whether organised, quality-standardised mental healthcare can be scaled profitably across India's diverse regional markets.
Frequently Asked Questions
Q: What does Jagruti Rehabilitation Centre actually do?
A: Jagruti runs residential and outpatient facilities that provide structured, clinically supervised care for mental health conditions, addiction (substance dependence), and dementia. It combines psychiatric support, therapy, and recovery programmes under one platform — a departure from the standalone clinics that dominate Indian mental healthcare.
Q: Why did Alkemi lead this round if they had not invested in mental health before?
A: Alkemi sees organised, facility-based mental health care as one of the last large unmet-need categories in Indian healthcare. The fragmented market structure and growing demand from corporates, insurers, and families creates a strong investment case for a platform player with the clinical credibility and systems to scale consistently.
Q: How big is the mental healthcare market opportunity in India?
A: India has over 150 million people estimated to be living with some form of mental illness, served by fewer than 10,000 psychiatrists. Treatment gaps exceed 80%. This creates a massive addressable market for structured providers like Jagruti that can offer quality-controlled care at scale.
Q: What is the 3–4 year target for Jagruti after this round?
A: The company has publicly stated a goal of operating 40+ centres and 4,000+ beds across Tier 1 and Tier 2 Indian cities within 3 to 4 years, funded by this Series A and future capital raises as the business scales.